SLS
Sellas Life Sciences Group Inc
๐บ๐ธ NYSE/NASDAQ
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-6.00%
Annual Growth
5 years average annual capital growth
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor. GPS is a cancer immunotherapeutic agent licensed by Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed by GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of mainland China, Hong Kong, Macau, and Taiwan.
๐ Performance
Price History*
-100.00%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$1.40
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in SLS
1
๐ Total Capital Earnings
N/A
๐ Average investment frequency
41 weeks
๐ต Average investment amount
$653
โฐ Last time a customer invested in SLS
389 days
SLS investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
100%
35 - 90
๐ Legal gender of investors
Female
Male
100%
Pearlers who invest in SLS also invest in...
๐ Performance (5Yr p.a)
1000.14%
๐ Share price
$161.96 USD
๐ Performance (5Yr p.a)
31.40%
๐ Share price
$163.85 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
28.07%
๐ Share price
$23.76 USD
๐ HIGH PRICE GROWTH
Want more shares? Try these...
๐ Performance (5Yr p.a)
-19.30%
๐ Share price